Breeding sites of bluetongue vectors in northern Europe
نویسندگان
چکیده
منابع مشابه
Breeding sites of bluetongue vectors in northern Europe.
SIR, – Bluetongue has recently been spreading in northern Europe, starting in Belgium and the Netherlands in August 2006. In 2006 there were 695 outbreaks in Belgium (399 sheep farms and 296 cattle farms). In 2007, according to data provided by the Federal Agency for the Safety of the Food Chain (www.afsca.be), 6598 Belgian farms were affected (4187 cattle farms, 2398 sheep farms and 13 goat fa...
متن کاملBreeding Sites of Bluetongue Virus Vectors, Belgium
1. Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174–9. 2. Hayes EB, Gubler DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med. 2006;57:181–94. DOI: 10.1146/annurev.med.57.121304.131418 3. Burt FJ, Grobbelaar ...
متن کاملBluetongue in northern Europe.
This publication was also sponsored by the European Commission (Health and Consumer Protection Directorate-General), the Veterinary and Agrochemical Research Centre, Brussels The Institute of Tropical Medicine, Antwerp the Notre-Dame de la Paix University Faculties of Namur, the Federal Public Service of Public Health, Food Chain Security and Environment, Brussels and the Federal Agency for the...
متن کاملBluetongue in Europe
Bluetongue (BT) is a potentially devastating midge-borne disease of ruminants that recently spread across Europe from its traditional tropical endemic areas. Historically, bluetongue virus (BTV) made only brief and rare incursions into fringe areas of Europe, with the Afro-Asian biting midge vector Culicoides imicola being largely responsible for transmission. Since 1998, however, different str...
متن کاملBluetongue vaccines in Europe.
The article reviews the history, present status and the future of BT vaccines in Europe. So far, an attenuated (modified live viruses, MLV) and inactivated virus vaccines against BT were developed and used in the field. Moreover, the virus-like particles (VLPs) produced from recombinant baculovirus, and live recombinant vaccinia or canarypox virus-vectored vaccines were tested in the laboratory...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Veterinary Record
سال: 2008
ISSN: 0042-4900
DOI: 10.1136/vr.162.4.131